Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Opioid
Sort By
Newest First
Sign in
1 / 1
1 / 1
Opioid
Trevena Announces FDA Approval of OLINVYK Injection
Trevena
PR-M08-20-NI-30
Aug 18, 2020
Opioid Disorder
Braeburn Submits Request for Final Approval of BRIXADI for the Treatment of Opioid Use Disorder
Braeburn
PR-M06-20-NI-014
Jun 11, 2020
Opioid Crisis
J&J Awaits Judge’s Decision in Lawsuit Filed by Oklahoma Over the Opioid Crisis
Nice Insight
PAO-M07-19-NI-021
Jul 22, 2019
Opioid Abuse
Opioid Abuse is Linked to a Rise in Infectious Diseases
Emilie Branch
Pharma's Almanac
PAO-M07-19-NI-016
Jul 10, 2019
Opioid Crisis
Analysis of Medicare Prescriptions Uncovers Role Surgeons Played in Opioid Crisis
Nice Insight
PAO-M07-19-NI-002
Jul 01, 2019
Opioid Crisis
Oklahoma vs. Johnson & Johnson Opioid Crisis Trial
Nice Insight
PAO-M06-19-NI-006
Jun 13, 2019
Pain Treatment
Eli Lilly Acquires Rights to Non-Opioid Pain Treatment
Nice Insight
PAO-M05-19-NI-038
May 31, 2019
Generic
First Generic Nalaxone Nasal Spray Approved by FDA
Emilie Branch
Pharma's Almanac
PAO-M05-19-NI-006
May 02, 2019
Opioid Treatment
Failed Depression Drug Could be Opioid Addiction Treatment
Emilie Branch
Pharma's Almanac
PAO-M04-19-NI-012
Apr 10, 2019
New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant
Abbott
PA3370
Nov 20, 2018
Opioids
Proposed Opioid Bill Includes New Payment Disclosures
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M10-18-NI-007
Oct 04, 2018
FDA Approval
Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market
Dr. Reddy's Laboratories
PR-M06-18-NI-063-4098
Jun 19, 2018
Clinical Data
New Data for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Low Back Pain in Adult Patients New to Opioid Therapy
Nektar Therapeutics
PR-M06-18-NI-058
Jun 18, 2018
FDA Approval
New Treatment for Management of Opioid Withdrawal Symptoms Approved by FDA
Emilie Branch
Pharma's Almanac
PAO-M05-18-NI-019
May 24, 2018
FDA Approval
FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults
U.S. Food & Drug Administration
PR-M05-18-NI-079
May 21, 2018
